SCHEMBL27010063

SCHEMBL27010063

c1ccc(-c2ccc3cc(-c4c5ccccc5c(-c5cccc6oc7ccc(-c8ccccc8)cc7c56)c5ccccc45)ccc3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 5/20 0.43
▸ PLA2G4A P47712 5/20 0.43
▸ PGR P06401 1/20 0.41
▸ PLA2G10 O15496 1/20 0.41
▸ ESR1 P03372 2/20 0.40
▸ ESR2 Q92731 2/20 0.40
▸ CASP3 P42574 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39
▸ PIM1 P11309 1/20 0.36
▸ CSNK2A2 P19784 1/20 0.36
▸ CSNK2B P67870 1/20 0.36
▸ PIM3 Q86V86 1/20 0.36
▸ PIM2 Q9P1W9 1/20 0.36
▸ ANO1 Q5XXA6 1/20 0.35
▸ CYP1A1 P04798 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ FYN P06241 1/20 0.35
▸ MAPK3 P27361 1/20 0.35
▸ AHR P35869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24292823 0.97 PLA2G2A (0.41) PLA2G2APLA2G4APGRPLA2G10ESR1
SCHEMBL27010159 0.96 PLA2G2A (0.41) PLA2G2APLA2G4APGRPLA2G10ESR1
SCHEMBL27010125 0.95 PLA2G2A (0.41) PLA2G2APLA2G4APGRPLA2G10ESR1
SCHEMBL21131853 0.95 PLA2G2A (0.43) PLA2G2APLA2G4APGRPLA2G10ESR1
SCHEMBL20363671 0.95 PGR (0.40) PLA2G2APLA2G4APGRPLA2G10ESR1
SCHEMBL27331711 0.94 PLA2G2A (0.40) PLA2G2APLA2G4APGRPLA2G10ESR1
SCHEMBL23426624 0.94 PLA2G2A (0.38) PLA2G2APLA2G4APGRPLA2G10ESR1
SCHEMBL23426938 0.93 PLA2G2A (0.46) PLA2G2APLA2G4APGRPLA2G10CASP3
SCHEMBL23426856 0.93 PLA2G2A (0.47) PLA2G2APLA2G4APGRPLA2G10CASP3
SCHEMBL21131845 0.93 PLA2G2A (0.47) PLA2G2APLA2G4APGRPLA2G10CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EED, EML4, ESR1 PLA2G2A 3402/4885PLA2G4A 4288/4885PGR 2165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback